E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4 Stability:T23 Acuteness:T24
E5	Condition:T5 Name:T6
E6	Eq-Comparison:T18 Operator:T7 Unit:T12 Value:T14
E7	Eq-Comparison:T19 Temporal-Unit:T10 Value:T16 Temporal-Period:T8
E8	Eq-Comparison:T20 Temporal-Unit:T11 Value:T17 Temporal-Period:T9
E2	Condition:T21 Name:T22 Temporality:E31
E9	Modifier:T26 Modifies:T4
E10	Study:T27 
E13	Study:T29 
E14	Observation:T30 Name:T31
E15	Condition:T32 Name:T33
E16	Modifier:T34 Modifies:T33
E17	Modifier:T35 Modifies:T33
E19	Exception:T37 From:E15 Except:E5
E20	Procedure:T38 Name:T39 Temporality:E21
E21	Eq-Comparison:T40 Temporal-Period:T41
E22	Observation:T42 Name:T43 Numeric-Filter:E6
E23	Study:T15 
E24	Study:T44 
E27	Drug:T47 Name:T48 Temporality:E7
E28	Drug:T49 Name:T50 Temporality:E8
E30	Modifier:T52 Modifies:E1
E31	Eq-Comparison:T53 Temporal-Period:T54
E32	Modifier:T55 Modifies:T39
T1	Condition 488 504	systemic disease
T2	Condition-Name 488 504	systemic disease
T3	Condition 106 117	blepharitis
T4	Condition-Name 106 117	blepharitis
T5	Condition 296 307	blepharitis
T6	Condition-Name 296 307	blepharitis
T7	Eq-Operator 346 347	>
T10	Eq-Temporal-Unit 430 434	days
T11	Eq-Temporal-Unit 463 469	months
T12	Eq-Unit 351 355	mmHg
T14	Eq-Value 348 350	21
T16	Eq-Value 427 429	30
T17	Eq-Value 460 462	12
T18	Eq-Comparison 346 355	> 21 mmHg
T19	Eq-Comparison 422 434	past 30 days
T20	Eq-Comparison 455 469	past 12 months
T21	Condition 36 47	blepharitis
T22	Condition-Name 36 47	blepharitis
T23	Stability 90 102	exacerbation
T24	Acuteness 84 89	acute
T26	Modifier 121 130	both eyes
T27	Study 134 143	Screening
T29	Study 148 156	Baseline
T30	Observation 193 221	best-corrected visual acuity
T31	Observation-Name 193 221	best-corrected visual acuity
T32	Condition 247 258	abnormality
T33	Condition-Name 247 258	abnormality
T34	Modifier 266 273	eyelids
T35	Modifier 277 283	lashes
T37	Exception 285 295	other than
T38	Procedure 329 336	surgery
T39	Procedure-Name 329 336	surgery
T40	Eq-Comparison 313 321	previous
T41	Eq-Temporal-Period 313 321	previous
T42	Observation 342 345	IOP
T43	Observation-Name 342 345	IOP
T15	Study 359 368	Screening
T44	Study 372 380	Baseline
T47	Drug 406 414	steroids
T48	Drug-Name 406 414	steroids
T8	Eq-Temporal-Period 422 426	past
T9	Eq-Temporal-Period 455 459	past
T49	Drug 438 447	retinoids
T50	Drug-Name 438 447	retinoids
T52	Modifier 475 487	uncontrolled
T53	Eq-Comparison 25 32	history
T54	Eq-Temporal-Period 25 32	history
T55	Modifier 322 328	eyelid
A1	Eq-Operator-Value T7 GT
A4	Eq-Temporal-Unit-Value T10 day
A5	Eq-Temporal-Unit-Value T11 month
A6	Stability-Value T23 change
A9	Eq-Temporal-Period-Value T41 past
A10	Observation-Type-Value E22 measurement
A2	Eq-Temporal-Period-Value T8 past
A3	Eq-Temporal-Period-Value T9 past
A12	Eq-Temporal-Period-Value T54 past
A13	Acuteness-Type-Value T24 acute
R1	And Arg1:E2 Arg2:E3
R2	During Arg1:E9 Arg2:E10
R3	And Arg1:E10 Arg2:E13
R4	Or Arg1:E16 Arg2:E17
R5	Or Arg1:E23 Arg2:E24
R6	During Arg1:E22 Arg2:E23
R7	Or Arg1:E27 Arg2:E28
